UiPath's share price has risen in recent months despite ongoing losses and slow growth. While market conditions are stable, there is still elevated deal scrutiny and longer sales cycles, particularly ...

UiPath Inc. (NYSE:PATH) is one of the best mid cap AI stocks to buy right now. UiPath Inc. (NYSE:PATH) is one of the best midcap AI stocks to buy right now. On August 1, 2025, UiPath announced the ...

NEW YORK--(BUSINESS WIRE)--UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced that it has been named a Leader in Intelligent Document Processing for the ...

UiPath isn't just riding the AI wave -- it's quietly building the infrastructure beneath it. To get there, UiPath is positioning itself around three strategic pillars: expanding automation ...

Omega Healthcare partnered with UiPath to automate medical billing and other administrative tasks. The revenue cycle management company has saved employees hours with its AI document-processing tool.

UiPath Inc (NYSE: PATH) opened more than 20% up this morning after the software firm unveiled strategic partnerships with four big names – Nvidia, OpenAI, Google, and Snowflake. The announcement, made ...

UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...

UiPath is dominating the robotic process automation market. Its tools can help businesses streamline their operations and cut costs. But it could face tough competition from newer generative AI ...

UiPath is moving beyond simple, rule-based bots toward "agentic automation." Partnerships are helping to drive scalability of this evolving business. UiPath’s focus on security and transparency could ...

UiPath (PATH) is positioned as a Leader among the 29 technology providers for its vision, capabilities, and market impact of its trusted, scalable, and open platform that is driving agentic automation ...